2P5A0138-square-webb

Jesper Söderqvist, Ph.D

Board of Directors since 2013

Member of the Remuneration Committee since 2020

Education/Background:  M.Sc.Eng. from KTH Royal Institute of Technology. Ph.D. in Physics from KTH Royal Institute of Technology and CERN. He has previously held the positions of CEO and Board member at Arcoma, Vice President for Elekta AB’s neuroscience division, General Manager for mammography at Philips Healthcare, and CEO at Sectra Mamea.

Current Assignments:  Jesper is CEO of Boule Diagnostics AB, as well as Board member and CEO of Dekatria AB.

Holdings:  directly and indirectly 41,085 Class A shares and 38,200 Class B shares, 25,000 TO4, 25,000 TO7, and 25,000 TO10

Some of our Collaborations

>3200

Numbers of patients in studies

24

Publications

10

Pharma Contracts